Amye J Tevaarwerk1,2, William G Hocking3, Kevin A Buhr4, Mindy Gribble3, Lori A Seaborne5, Kari B Wisinski2,6, Mark E Burkard1,2, Thomas Yen6, Douglas A Wiegmann6, Mary E Sesto2,7. 1. Division of Hematology/Oncology, Department of Medicine, The University of Wisconsin-Madison, Madison, Wisconsin. 2. The University of Wisconsin-Madison Carbone Cancer Center, Madison, Wisconsin. 3. Marshfield Clinic Health System, Marshfield, Wisconsin. 4. Department of Biostatistics and Medical Informatics, The University of Wisconsin-Madison, Madison, Wisconsin. 5. Department of Surgery, The University of Wisconsin-Madison, Madison, Wisconsin. 6. The University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin. 7. Department of Medicine, The University of Wisconsin-Madison, Madison, Wisconsin.
Abstract
BACKGROUND:Survivorship care plans (SCPs) and care-planning sessions have been recommended for over a decade, yet evidence for their benefit remains mixed. In a randomized trial, changes in survivor knowledge and satisfaction before and after the receipt of an SCP were assessed. METHODS:Patients with breast cancer who had completed curative-intent treatment were randomized to immediate versus delayed receipt of an individualized SCP. All participants completed the modified Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer and the Preparing for Life As a New Survivor survey to assess individual knowledge about cancer diagnosis, treatment, side effects, and follow-up as well as satisfaction with communication and care coordination. Surveys were completed at baseline, at 4 weeks (before delayed receipt), and again at 12 weeks (after all participants had received SCPs); the primary outcome was change in knowledge at 4 weeks. RESULTS: In total, 127 eligible women were randomized. An improvement in individual knowledge was observed between baseline and week 12 for both arms combined (+1.6; 95% confidence interval, 0.9-2.3; P < .001). There was no statistically significant difference in the change in knowledge from baseline through week 4 between the arms. No significant change occurred for satisfaction scores over time. CONCLUSIONS: This randomized trial of immediate versus delayed SCP receipt demonstrated a small improvement (4%) in survivor knowledge. However, this improvement did not appear to be related to SCP provision. The authors hypothesized that the improvement was because of repeated administration of the knowledge survey. If improved survivor knowledge is a goal, then strategies beyond the 1-time provision and review of an SCP should be explored.
RCT Entities:
BACKGROUND: Survivorship care plans (SCPs) and care-planning sessions have been recommended for over a decade, yet evidence for their benefit remains mixed. In a randomized trial, changes in survivor knowledge and satisfaction before and after the receipt of an SCP were assessed. METHODS:Patients with breast cancer who had completed curative-intent treatment were randomized to immediate versus delayed receipt of an individualized SCP. All participants completed the modified Wisconsin Survey of Cancer Diagnosis and Management in Breast Cancer and the Preparing for Life As a New Survivor survey to assess individual knowledge about cancer diagnosis, treatment, side effects, and follow-up as well as satisfaction with communication and care coordination. Surveys were completed at baseline, at 4 weeks (before delayed receipt), and again at 12 weeks (after all participants had received SCPs); the primary outcome was change in knowledge at 4 weeks. RESULTS: In total, 127 eligible women were randomized. An improvement in individual knowledge was observed between baseline and week 12 for both arms combined (+1.6; 95% confidence interval, 0.9-2.3; P < .001). There was no statistically significant difference in the change in knowledge from baseline through week 4 between the arms. No significant change occurred for satisfaction scores over time. CONCLUSIONS: This randomized trial of immediate versus delayed SCP receipt demonstrated a small improvement (4%) in survivor knowledge. However, this improvement did not appear to be related to SCP provision. The authors hypothesized that the improvement was because of repeated administration of the knowledge survey. If improved survivor knowledge is a goal, then strategies beyond the 1-time provision and review of an SCP should be explored.
Authors: Brad J Zebrack; Debra A Eshelman; Melissa M Hudson; Ann C Mertens; Kelly L Cotter; Barbara M Foster; Lauren Loftis; Margaret Sozio; Kevin C Oeffinger Journal: Cancer Date: 2004-02-15 Impact factor: 6.860
Authors: Kaleigh J Bulloch; Melinda L Irwin; Anees B Chagpar; Lajos Pusztai; Brigid K Killelea; Nina R Horowitz; Erin W Hofstatter; Maysa M Abu-Khalaf; Michael DiGiovanna; Gina G Chung; Tara B Sanft Journal: J Oncol Pract Date: 2015-03 Impact factor: 3.840
Authors: Sarah A Birken; Robin Urquhart; Corrine Munoz-Plaza; Alexandra R Zizzi; Emily Haines; Angela Stover; Deborah K Mayer; Erin E Hahn Journal: J Cancer Surviv Date: 2018-03-23 Impact factor: 4.442
Authors: Dawn L Hershman; Heather Greenlee; Danielle Awad; Kevin Kalinsky; Matthew Maurer; Grace Kranwinkel; Lois Brafman; Ramona Jayasena; Wei-Yann Tsai; Alfred I Neugut; Katherine D Crew Journal: Breast Cancer Res Treat Date: 2013-03-31 Impact factor: 4.872
Authors: Eva Grunfeld; Jim A Julian; Gregory Pond; Elizabeth Maunsell; Douglas Coyle; Amy Folkes; Anil A Joy; Louise Provencher; Daniel Rayson; Dorianne E Rheaume; Geoffrey A Porter; Lawrence F Paszat; Kathleen I Pritchard; André Robidoux; Sally Smith; Jonathan Sussman; Susan Dent; Jeffrey Sisler; Jennifer Wiernikowski; Mark N Levine Journal: J Clin Oncol Date: 2011-10-31 Impact factor: 44.544
Authors: Elizabeth A Kvale; Chao-Hui Sylvia Huang; Karen M Meneses; Wendy Demark-Wahnefried; Sejong Bae; Casey B Azuero; Gabrielle B Rocque; Kerri S Bevis; Christine S Ritchie Journal: Cancer Date: 2016-07-07 Impact factor: 6.860
Authors: Nina S Kadan-Lottick; Leslie L Robison; James G Gurney; Joseph P Neglia; Yutaka Yasui; Robert Hayashi; Melissa Hudson; Mark Greenberg; Ann C Mertens Journal: JAMA Date: 2002-04-10 Impact factor: 157.335
Authors: Claire Snyder; Youngjee Choi; Katherine C Smith; Renee F Wilson; Christina T Yuan; Paul C Nathan; Allen Zhang; Karen A Robinson Journal: JNCI Cancer Spectr Date: 2022-03-02